Bio-Rad Laboratories BIO
NYSE BIO
$382.40 +3.37 (+0.89%)
As of: Sep 17, 2026 · 3:59 PM EDT

Bio-Rad Laboratories (BIO) Change in Accured Expenses (2009 - 2017)

Bio-Rad Laboratories' (BIO) quarterly Change in Accured Expenses came in at $5.0 million in Q3 2017, down 82.01% year-over-year from $27.9 million in Q3 2016, and down 86.43% quarter-over-quarter from $37.0 million in Q2 2017.

Analysis

Bio-Rad Laboratories (BIO) Change in Accured Expenses (2009 - 2017) Analysis & Trends

Bio-Rad Laboratories (BIO) has reported Change in Accured Expenses for 9 consecutive years, with $5.0 million the latest figure, recorded in Q3 2017.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Thermo Fisher Scientific 241.68 Bn 237.61 Bn 8.34 Bn -
2 Danaher 147.34 Bn 142.99 Bn 3.61 Bn -249.00 Mn
3 Agilent Technologies 43.34 Bn 41.59 Bn 1.04 Bn 34.00 Mn
4 Illumina 34.58 Bn 33.41 Bn 770.00 Mn 23.00 Mn
5 Revvity 16.31 Bn 15.29 Bn 416.87 Mn -4.19 Mn
6 Bio-Techne 11.28 Bn 11.01 Bn 211.39 Mn 3.53 Mn
7 Bio-Rad Laboratories 10.16 Bn 8.54 Bn 345.80 Mn -
8 Repligen 9.77 Bn 8.75 Bn 110.04 Mn 12.13 Mn
9 10x Genomics 9.45 Bn 8.90 Bn 112.50 Mn 3.12 Mn
10 Bruker 9.26 Bn 9.04 Bn 416.00 Mn -91.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2017 5.02 Mn
Jun 30, 2017 37.00 Mn
Mar 31, 2017 -61.16 Mn
Sep 30, 2016 27.92 Mn
Jun 30, 2016 15.10 Mn
Mar 31, 2016 -47.67 Mn
Sep 30, 2015 40.97 Mn
Jun 30, 2015 -15.36 Mn
Mar 31, 2015 -7.75 Mn
Sep 30, 2014 40.75 Mn
Jun 30, 2014 -8.32 Mn
Mar 31, 2014 7.32 Mn
Sep 30, 2013 30.53 Mn
Jun 30, 2013 -2.11 Mn
Mar 31, 2013 -9.15 Mn
Sep 30, 2012 538,000.00
Jun 30, 2012 1.33 Mn
Mar 31, 2012 -7.78 Mn
Sep 30, 2011 -3.53 Mn
Jun 30, 2011 22.52 Mn